AliveCor and Acutus Medical will collaborate to assess the integration of data collection tools across the cardiology continuum of care, which the companies say may help guide decision making in the management of cardiac arrhythmia patients.
The collaboration includes a US post-market pilot study to gain insights on how physicians can utilise the KardiaMobile device to facilitate pre-ablation and/or post-ablation remote monitoring. Information gathered through the trial will enable more informed decisions in the treatment of complex arrhythmias to potentially improve patient outcomes, AliveCor and Acutus said in a press release.
“Utilising data from across the continuum of care to complement our core mapping and therapy technologies furthers our vision to become the provider-of-choice and democratise the treatment of complex arrhythmia patients,” said Vince Burgess, president and CEO of Acutus. “AliveCor will be an excellent partner to help our physicians assess important clinical patient information as they manage and treat their cardiac arrhythmia patients.”
Acutus offers a portfolio of differentiated electrophysiology tools and products that provide a solution for catheter-based treatment of cardiac arrhythmias. The company’s core technology is the AcQMap 3D Imaging and Mapping System, a noncontact mapping system enabling the creation of full chamber global activation maps in real-time.
“AliveCor is proud to partner with Acutus to advance understanding of the use of our shared technologies and how we can potentially improve the care and monitoring of cardiac patients,” said Priya Abani, CEO, AliveCor.
